UNSPSC 51283612: Rifamycin sv

This classification denotes an antitubercular agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DU69T8ZZPA. European Medicines Agency schedules Rifamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10310MIG. Rifamycin generally arises in the molecular formula C37H47NO12.

The term RIFAMYCIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, list 5.) RIFAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule rifamycin sv under HS 29419000. SMILES: CC1C(C2C3C(CC(C2O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H](/C=C/O[C@@]4(C(=O)C3C1O4)C)OC)C)OC(=O)C)C)O)C)O)C)/C)O)O.

UNSPSC 51283612 Rifamycin sv is a Commodity code nominally designating a single antibiotic product, but the recent state and local opportunities tagged to this code show no actual procurement of rifamycin itself. Instead, they cover a wide range of pharmaceuticals, medical supplies, and pharmacy-benefit program infrastructure — naloxone kits, first-aid supplies for emergency responders, generic multi-source pharmaceuticals through cooperative purchasing, and direct-to-manufacturer prescription fulfillment strategies. The mismatch between the code's nominal scope and what jurisdictions are actually buying under it suggests either systematic miscoding in state and local procurement systems or that this code has been repurposed as a catch-all for pharmaceutical and medical-supply categories more broadly. The issuing bodies include a county health department (Seminole County, Florida), a municipal fire department (Tampa Fire Department via the City of Tampa), a state health and human services agency (Texas HHS Commission), and a multi-state cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance serving state and local governments across participating states including Oregon). Set-asides appear selectively — the Tampa procurement explicitly reserves the opportunity for certified Small Local Business Enterprises with a 5 percent bid discount, while the Minnesota cooperative purchasing RFP does not specify set-aside designations.

Recent activity clusters in Florida and Texas with the Minnesota cooperative vehicle serving a multi-state footprint. Representative opportunities include Seminole County's competitive bid (IFB 60459723LAS, due July 26, 2023, but posted June 30, 2026 — a date anomaly suggesting backend data errors) for 1,900 units of naloxone and 800 drug deactivation systems annually; the City of Tampa's invitation to bid (26P00145, due March 13, 2026) for 169 line items of medical and first-aid supplies estimated at $700,000 and sheltered for Small Local Business Enterprises; the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to supply state and local facilities; and the Texas HHS Commission's Request for Information (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The code shows active procurement volume but displays significant code-to-scope misalignment that warrants clarification before pursuit.